aspirin has been researched along with deferoxamine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Halliwell, B; Longhurst, JC; Stahl, GL | 1 |
| Barradas, MA; Dandona, P; Hoffbrand, AV; Jeremy, JY; Kontoghiorghes, GJ; Mikhailidis, DP | 1 |
| Arey, BJ; Mahanty, S; Schwarz, KB; Tolman, K | 1 |
| Huang, HS; Longhurst, JC; Stahl, GL | 1 |
| Macdonald, VW; Motterlini, R | 1 |
| Cederbaum, AI; Chen, Q; Galleano, M | 1 |
| Calzada, C; Lagarde, M; Vericel, E | 1 |
| Abate, A; Oberle, S; Podhaisky, HP; Polte, T; Schröder, H | 1 |
| Barry, OP; FitzGerald, GA; Ghiselli, A; Iuliano, L; Pasin, M; Praticó, D; Sabatino, G; Violi, F | 1 |
| De Marzi, CA; Magliari, F; Perniola, R; Rosatelli, MC | 1 |
| Hellrung, DJ; Johnson, CD; Link, CJ; Manuszak, RP; Shackelford, RE; Steele, TA; Wang, S | 1 |
| Chang, CH; Chen, YC; Fan, SC; Huang, CH; Liu, C; Tsai, AL; Wu, CC | 1 |
| Bojić, M; Guengerich, FP; Nagy, LD; Sedgeman, CA | 1 |
1 review(s) available for aspirin and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for aspirin and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Hydrogen peroxide-induced cardiovascular reflexes. Role of hydroxyl radicals.
Topics: Animals; Aspirin; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Cats; Deferoxamine; Dose-Response Relationship, Drug; Duodenum; Electrophysiology; Female; Free Radicals; Gallbladder; Hemodynamics; Hydrogen Peroxide; In Vitro Techniques; Ischemia; Male; Mesentery; Reflex; Reperfusion; Stomach; Thiourea | 1992 |
Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Deferiprone; Deferoxamine; Epinephrine; Humans; Iron; Iron Chelating Agents; Lipoxygenase; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Pyridones; Thromboxane A2 | 1989 |
Iron chelation as a possible mechanism for aspirin-induced malondialdehyde production by mouse liver microsomes and mitochondria.
Topics: Animals; Aspirin; Deferoxamine; Dose-Response Relationship, Drug; Electric Conductivity; Iron Chelating Agents; Lipid Peroxides; Male; Malonates; Malondialdehyde; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mitochondria, Liver | 1988 |
Cardiac-cardiovascular reflexes induced by hydrogen peroxide in cats.
Topics: Animals; Aspirin; Cardiovascular System; Cats; Deferoxamine; Denervation; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Heart; Hydrogen Peroxide; Male; Reflex; Thiourea | 1995 |
Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl)fumarate cross-linked hemoglobin (alpha alpha Hb).
Topics: Acetylcholine; Animals; Arginine; Aspirin; Blood Pressure; Blood Substitutes; Deferoxamine; Drug Synergism; Heart; Hemoglobins; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Rabbits; Vasoconstriction | 1994 |
Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1.
Topics: alpha-Tocopherol; Antioxidants; Apoptosis; Ascorbic Acid; Aspirin; Carcinoma, Hepatocellular; Cell Survival; Chromans; Cytochrome P-450 CYP2E1; Deferoxamine; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; Oleic Acid; Phenylenediamines; Propyl Gallate; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vitamin E | 1997 |
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Deferoxamine; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Hydrazines; Hydrogen Peroxide; Leukotrienes; Lipid Peroxides; Oligopeptides; Peroxides; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; tert-Butylhydroperoxide; Thromboxane B2; Vitamin E | 1997 |
Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway.
Topics: Animals; Antioxidants; Aspirin; Cattle; Cell Survival; Cells, Cultured; Deferoxamine; Dose-Response Relationship, Drug; Endothelium, Vascular; Ferritins; Gene Expression; RNA, Messenger | 1998 |
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
Topics: Adult; Aspirin; Blood Platelets; Catalase; Chelating Agents; Collagen; Deferoxamine; Deoxyribose; Diuretics, Osmotic; Dose-Response Relationship, Drug; Edetic Acid; Enzyme Inhibitors; Female; Humans; Hydroxyl Radical; Indoles; Iron; Isoquinolines; Male; Maleimides; Mannitol; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1999 |
High-risk pregnancy in beta-thalassemia major women. Report of three cases.
Topics: Adult; Aspirin; beta-Thalassemia; Cardiomyopathy, Dilated; Deferoxamine; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy, High-Risk | 2000 |
Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells.
Topics: Aspirin; Ataxia Telangiectasia; Cell Line; Chromosomal Instability; Colony-Forming Units Assay; Deferoxamine; Dose-Response Relationship, Drug; Ferritins; Fibroblasts; G2 Phase; Humans; Iron Chelating Agents; Oxidative Stress; tert-Butylhydroperoxide | 2003 |
Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Aspirin; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cellular Microenvironment; Cobalt; Cyclooxygenase 2; Deferoxamine; Female; Fractures, Bone; Humans; Indomethacin; Mice; Osteoblasts; Poly(ADP-ribose) Polymerases; Sodium Salicylate; Sulindac | 2012 |
Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.
Topics: Aspirin; Benzaldehydes; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deferoxamine; Enzyme Inhibitors; Humans; Hydroxylation; Isoenzymes; Microsomes, Liver; NADP; Organophosphates; Oxidation-Reduction; Reactive Oxygen Species; Recombinant Proteins; Salicylic Acid | 2015 |